QUINVAXEM

Swiss trademark · 570843 · Word mark · Deleted

Register entry

Registration number
570843
Application number
51227/2008
Status
Deleted
Type
Word mark
Filed
Jan 30, 2008
Registered
Apr 25, 2008
Published
May 14, 2008
Deleted
Sep 4, 2018
Reason
Not renewed
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate, Impfstoffe, Adjuvantien für Impfstoffe und diagnostische Präparate für den medizinischen Gebrauch.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 4, 2018

    Deleted, not renewed

    Published in Swissreg on 04.09.2018

  2. Sep 7, 2016

    Transferred

    Owner
    Novartis AG, 4002 Basel → GlaxoSmithKline Biologicals S.A., Rue de l'Institut 89, 1330 Rixensart, Belgium
    Representative
    Baker & McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich → A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 07.09.2016

  3. Apr 30, 2013

    Agent entered

    Representative
    Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich → Baker & McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich

    Published in Swissreg on 30.04.2013

  4. Feb 17, 2009

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich

    Published in Swissreg on 17.02.2009

  5. May 14, 2008

    Registered

    Published in the SOGC no. 91 of 14.05.2008

Parties

Holder

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89, 1330 Rixensart, BE

Agent

A. W. Metz & Co. AG in Liquidation

A.W. Metz & Co. AG

Kreuzbühlstrasse 8, 8008 Zürich

In liquidation

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.